Compare Cipta Sarana Medika Tbk. (DKHH) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Cipta Sarana Medika Tbk. and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 71K). Which is the better fit depends on your goals.
| DKHH | OBAT | |
|---|---|---|
Market Cap | 158.12B | 167.37B |
Volume | 8.21M | 71K |
Lot | 82.15K | 710 |
Turnover | 515.2M | 17.51M |
Average Price | 62.72 | 246.63 |
Value | 515.2M | 17.51M |
Indicative Equilibrium Price | 63 | 246 |
Indicative Equilibrium Volume | 1.33K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
